tiprankstipranks
Organogenesis Highlights Strategic Focus in Investor Presentation
PremiumCompany AnnouncementsOrganogenesis Highlights Strategic Focus in Investor Presentation
2M ago
Organogenesis price target raised to $6 from $4 at Morgan Stanley
Premium
The Fly
Organogenesis price target raised to $6 from $4 at Morgan Stanley
2M ago
Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges
Premium
Company Announcements
Organogenesis Holdings Reports Strong Q4 Earnings Amid Challenges
3M ago
Organogenesis reports Q4 EPS 4c, consensus 2c
PremiumThe FlyOrganogenesis reports Q4 EPS 4c, consensus 2c
3M ago
Organogenesis files to sell 130K shares of common stock for holders
Premium
The Fly
Organogenesis files to sell 130K shares of common stock for holders
5M ago
Organogenesis assumed with an Equal Weight at Morgan Stanley
Premium
The Fly
Organogenesis assumed with an Equal Weight at Morgan Stanley
6M ago
Organogenesis reports Q3 EPS 9c, consensus (1c)
PremiumThe FlyOrganogenesis reports Q3 EPS 9c, consensus (1c)
6M ago
Organogenesis reports Q3 EPS 9c, consensus (1c)
Premium
The Fly
Organogenesis reports Q3 EPS 9c, consensus (1c)
6M ago
Organogenesis sees FY24 revenue $455-$480M, consensus $456.15M
Premium
The Fly
Organogenesis sees FY24 revenue $455-$480M, consensus $456.15M
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100